These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22481515)

  • 1. [Recent advances in imaging in Parkinson disease].
    Baba T; Takeda A
    Brain Nerve; 2012 Apr; 64(4):423-32. PubMed ID: 22481515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional imaging in Parkinson disease.
    Nandhagopal R; McKeown MJ; Stoessl AJ
    Neurology; 2008 Apr; 70(16 Pt 2):1478-88. PubMed ID: 18413571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging approaches to Parkinson disease.
    Brooks DJ
    J Nucl Med; 2010 Apr; 51(4):596-609. PubMed ID: 20351351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments of brain imaging for Parkinson's disease and related disorders.
    Piccini P; Brooks DJ
    Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation.
    Raff U; Hutchinson M; Rojas GM; Huete I
    Acad Radiol; 2006 Jun; 13(6):721-7. PubMed ID: 16679274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.
    Hilker R; Schweitzer K; Coburger S; Ghaemi M; Weisenbach S; Jacobs AH; Rudolf J; Herholz K; Heiss WD
    Arch Neurol; 2005 Mar; 62(3):378-82. PubMed ID: 15767502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J; Peppard R; Calne DB
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging cognitive and behavioral symptoms in Parkinson's disease.
    Antonelli F; Ray N; Strafella AP
    Expert Rev Neurother; 2010 Dec; 10(12):1827-38. PubMed ID: 21091314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital perisylvian syndrome: MRI and glucose PET correlations.
    Luat AF; Bernardi B; Chugani HT
    Pediatr Neurol; 2006 Jul; 35(1):21-9. PubMed ID: 16814081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Parkinson's disease biomarkers.
    Prakash KM; Tan EK
    Expert Rev Neurother; 2010 Dec; 10(12):1811-25. PubMed ID: 21091313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in diagnosis and differential diagnosis of Parkinson's disease.
    Tatsch K
    Neurodegener Dis; 2010; 7(5):330-40. PubMed ID: 20616567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we image premotor Parkinson disease?
    Marek K; Jennings D
    Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging in Movement Disorders.
    Maiti B; Perlmutter JS
    Semin Nucl Med; 2018 Nov; 48(6):513-524. PubMed ID: 30322477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders.
    Shen LH; Tseng YC; Liao MH; Fu YK
    J Biomed Biotechnol; 2011; 2011():439397. PubMed ID: 21541178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of brain imaging in early parkinsonism.
    Breen DP; Rowe JB; Barker RA
    BMJ; 2011 Feb; 342():d638. PubMed ID: 21345904
    [No Abstract]   [Full Text] [Related]  

  • 20. New ways to assess brain function in Parkinson disease.
    Karceski S
    Neurology; 2014 Nov; 83(22):e199-201. PubMed ID: 25422406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.